COMP <GO>
ALGN vs MRK // ENTERPRISE SCALE & MARKET CAP
Align Technology Inc. (NASDAQ) VS. Merck & Company Inc. Common Stock (new) (NYSE) • 15-METRIC TALLY: ALGN 1
— MRK 12
▲ ENTERPRISE SCALE & MARKET CAP LEADER: MRK
LAST: $149.89 (-2.49%) • MKT CAP: $10.92B
market-cap
$10.92B
LAST: $149.52 (+2.18%) • MKT CAP: $361.02B
market-cap
$361.02B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ALGN VS. MRK)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ALGN | MRK | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 67.20% | 74.80% | -7.60 | MRK | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 11.10% | 20.70% | -9.60 | MRK | /roic <GO> |
| EV/EBITDA & P/E Valuation | 17.0x | 15.3x | +1.70 | MRK | /valuation <GO> |
| Free Cash Flow Yield | 4.49% | 3.42% | +1.07 | ALGN | /fcf-yield <GO> |
| Operating Margin | 13.50% | 34.30% | -20.80 | MRK | /operating-margins <GO> |
| Net Profit Margin | 10.20% | 28.10% | -17.90 | MRK | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 1.30% | -0.40 | MRK | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.26% | -2.26 | MRK | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 5.19 | -0.57 | MRK | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.60% | 6.60% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.8 | 56.9 | -7.05 | MRK | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.90 | 0.92 | -0.02 | MRK | /macro-sensitivity <GO> |
| Forward P/E Multiple | 24.7x | 18.4x | +6.30 | MRK | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $10.92B | $361.02B | -$350.10B | MRK | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ALGN REV | MRK REV | ALGN GROSS % | MRK GROSS % | ALGN FCF | MRK FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.03B | $65.01B | 67.2% | 74.8% | $490.8M | $12.36B |
| FY 2024 | $4.00B | $64.17B | 70.0% | 76.3% | $622.7M | $18.10B |
| FY 2023 | $3.86B | $60.12B | 44.0% | 44.0% | $612.0M | $10.30B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ALGN // BETA 0.90
MRK // BETA 0.92